HANLY ANN M.
SEC CIK 1854528 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | EVP, CTO | 117.9K | $499.85 | $473.2K | 10 | 2021-11-29 | 2025-02-24 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
HANLY ANN M. made no open-market trades at VIR in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-24 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | EVP, CTO | S - Sale | $9.45 | -14.2K | 117.9K | -11% | -$133.9K | |
| 2024-04-02 | 2024-04-01 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | EVP, CTO | S - Sale | $10.05 | -2,711 | 132.1K | -2% | -$27.2K | |
| D | 2024-02-26 | 2024-02-22 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | EVP, CTO | S - Sale | $10.05 | -12.3K | 134.8K | -8% | -$123.6K |
| D | 2024-02-26 | 2024-02-22 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | EVP, CTO | A - Grant | $0.00 | +32.5K | 147.1K | +28% | $0 |
| 2023-03-31 | 2023-03-30 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | S - Sale | $22.77 | -2,627 | 114.6K | -2% | -$59.8K | |
| D | 2023-02-24 | 2023-02-23 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | S - Sale | $25.97 | -2,302 | 117.2K | -2% | -$59.8K |
| D | 2023-02-24 | 2023-02-22 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | A - Grant | $0.00 | +37.5K | 119.5K | +46% | $0 |
| 2022-03-31 | 2022-03-30 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | S - Sale | $26.24 | -2,627 | 81.5K | -3% | -$68.9K | |
| D | 2022-02-24 | 2022-02-22 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | A - Grant | $0.00 | +53.5K | 84.1K | +175% | $0 |
| I | 2021-12-01 | 2021-11-29 | VIR | Vir Biotechnology, Inc. | HANLY ANN M. | CTO | P - Purchase | $43.39 | +11.52 | 11.52 | New | +$499.85 |
Purchase Sale Sale after option exercise All abbreviations